Novel Inflammatory Prognostic Markers in Lung Cancer Patients Treated with Definitive Chemoradiotherapy
Primary lung cancer is the most common cancer worldwide and is an increasingly common problem. The primary endpoint of this study was; to investigate the effect of radiotherapy dose and neutrophil-lymphocyte ratio (NLR) on overall survival (OS) and progression-free survival (PFS). We retrospectively...
Saved in:
| Main Authors: | Hakan Harputluoglu, Alper Yeniçeri, Ahmet Gulmez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Selcuk University Press
2022-12-01
|
| Series: | Genel Tıp Dergisi |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2391896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Akciğerin Sarkomatoid Karsinomlarının Klinik ve Radyometabolik Özellikleri
by: Sevda Şener Cömert, et al.
Published: (2019-09-01) -
Analysis of Prognostic Factors in Sudden Idiopatic Sensorineural Hearing Loss
by: Erkun Tuncer, et al.
Published: (2022-04-01) -
Hemoglobin Level as a Prognostic Factor of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer
by: Berrin Yalçın, et al.
Published: (2024-11-01) -
The Appearances of Brain Metastases of Small Cell Lung Cancer on 18F-FDG PET/CT
by: Hasan Önner, et al.
Published: (2022-08-01) -
Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
by: Xiaofeng Duan, et al.
Published: (2025-01-01)